fda《良好药物警戒规范和药物流行学评估》.pdf

fda《良好药物警戒规范和药物流行学评估》.pdf

Guidance for Industry Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) March 2005 Clinical Medical J:\!GUIDANC\6359OCC.doc 03/22/05 Guidance for Industry

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档